Oral minoxidil has transitioned from a 1970s hypertension drug to a widely discussed hair-loss treatment, driven by heightened post-pandemic awareness and the rise of GLP-1 medications.
From Blood Pressure to Follicle Stimulation
Originally developed in the 1970s as a medication for severe hypertension, doctors soon noticed an unexpected side effect: increased hair growth. “Doctors noticed that many patients taking it began growing more hair, including on areas of the scalp where the hair had started thinning,” says Dr Chetna Chhabra, Clinical Lead, Clinikally.
“Low-dose oral minoxidil can encourage follicles to remain in the active growth phase for longer and may help resting follicles transition back into growth, eventually improving density and thickness,” adds Chhabra.
Rather than simply elevating scalp circulation as people often assume, the underlying physiological process is considerably more intricate. “It appears to influence several signals involved in follicle growth and survival, and the exact mechanism is still being studied,” says Chhabra. Crucially, minoxidil supports existing follicles; it cannot create new ones or address every cause of hair loss.
Pills Versus Topical Formulations
Opting for a pill can make oral treatment seem like the most straightforward progression, specifically for individuals who struggle to apply liquid or foam products regularly. Topical minoxidil remains the more established starting treatment, acting directly on the scalp with less systemic exposure. Internal delivery via the bloodstream allows oral minoxidil to reach the follicles, making it a viable option for individuals experiencing diffuse hair thinning or those who cannot stick to a topical regimen.
But convenience does not necessarily mean superiority. “Both oral and topical minoxidil can be effective for hair loss, but one is not automatically better than the other for every patient,” says Chhabra. Regarding men, she highlights findings from a 2024 randomised clinical trial showing that a daily 5mg dose of oral minoxidil performed similarly to a regimen of 5 per cent topical minoxidil applied twice daily over a 24-week period. Similarly, Dr Nirupama Parwanda, dermatologist and Founder of Zolie Skin Clinic, emphasises that sticking to a consistent regimen is vital for any long-term hair-loss therapy, noting that the ease of swallowing a pill must be weighed against its whole-body impact.
Identifying Root Causes and Individual Dosages
Dr Priyanka Sharma, Co-founder, Director and Chief Dermatologist at V6 Clinics, highlights that while heightened attention toward women’s hair thinning is positive, it risks oversimplifying the issue. “Hair thinning may result from hormonal changes, nutritional deficiencies, thyroid disorders, stress, genetics or scalp conditions, and treatment should address the underlying cause,” she says.
When questioned if oral minoxidil is meant solely for male patients, Chhabra quickly clarifies that it is equally suitable for women experiencing female pattern hair loss, which typically manifests as a widening of the central parting or an overall loss of hair density. “The dose is individualised according to the diagnosis, medical history, treatment goals, and tolerability,” she adds.
Systemic Risks and Off-Label Status
The allure of an oral pill can overshadow a critical difference: oral minoxidil acts systemically throughout the entire body rather than being confined to the head. Sharma cautions against viewing low-dose oral minoxidil simply as a harmless “hair-growth pill”. While many appropriately selected patients tolerate it well, she notes that it can impact blood pressure and fluid regulation. “It is also generally avoided during pregnancy and breastfeeding,” says Sharma.
For women, one potential side effect can be particularly unwelcome: hypertrichosis, or unwanted facial and body hair. Chhabra adds that the likelihood generally increases with dose. Light-headedness, headaches, palpitations and swelling around the ankles are other possible side effects, warn experts.
Timeline for Results and Clinical Outlook
Initial shifts can typically be observed around the three-to-four-month mark, according to Chhabra, whereas a dependable evaluation of hair thickness and density generally takes place at about six months. Parwanda is equally clear about managing expectations. “There should be no illusions of it being a ‘cure-all’ wonder drug. Its use for hair loss remains off-label, and long-term safety and efficacy continue to be studied,” she cautions.
References:
- Harper’s Bazaar India, August – September 2026 print issue.
